Mingyao Luo
Mingyao Luo
1
State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
1,
Mingyuan Du
Mingyuan Du
2
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
3
The Institute of Vascular Diseases, Central South University, Changsha, China
2,3,
Chang Shu
Chang Shu
1
State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
2
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
3
The Institute of Vascular Diseases, Central South University, Changsha, China
1,2,3,
Sheng Liu
Sheng Liu
1
State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
1,
Jiehua Li
Jiehua Li
2
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
3
The Institute of Vascular Diseases, Central South University, Changsha, China
2,3,
Lei Zhang
Lei Zhang
2
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
3
The Institute of Vascular Diseases, Central South University, Changsha, China
2,3,
Xin Li
Xin Li
2
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
3
The Institute of Vascular Diseases, Central South University, Changsha, China
2,3,*
1
State Key Laboratory of Cardiovascular Diseases, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
2
Department of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China
3
The Institute of Vascular Diseases, Central South University, Changsha, China
Edited and reviewed by:
Xiaohui Li, Central South University, China
✉*Correspondence: Xin Li, lixin1981@csu.edu.cn
This article was submitted to Respiratory Pharmacology, a section of the journal Frontiers in Pharmacology
Received 2021 Nov 25; Accepted 2021 Dec 7; Collection date 2021.
Keywords: biomarker, deep venous thrombosis, miRNA, molecular regulation, pulmonary embolism, treatment target
Copyright © 2022 Luo, Du, Shu, Liu, Li, Zhang and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.